Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
about
Mass casualties and health care following the release of toxic chemicals or radioactive material--contribution of modern biotechnology2013 Dade W. Moeller lecture: medical countermeasures against radiological terrorismThe use of proteomics to identify novel therapeutic targets for the treatment of disease.Proteomic patterns for cancer diagnosis--promise and challenges.Reduced transthyretin expression in sera of lung cancer.UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation.Applications of SELDI-MS technology in oncologyRadiation-induced changes in serum lipidome of head and neck cancer patients.Humoral response to a viral glycan correlates with survival on PROSTVAC-VFAssociation between plasma proteome profiles analysed by mass spectrometry, a lymphocyte-based DNA-break repair assay and radiotherapy-induced acute mucosal reaction in head and neck cancer patients.Profiling of low molecular weight proteins in plasma from locally irradiated individuals.Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancerRadiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissueDose-dependent metabolic alterations in human cells exposed to gamma irradiation.Proteomic technology for biomarker profiling in cancer: an updateSchizophrenia proteomics: biomarkers on the path to laboratory medicine?Radiation-induced biomarkers for the detection and assessment of absorbed radiation dosesDecreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.PicoGreen assay of circular DNA for radiation biodosimetry.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Hyperspectral Imaging as an Early Biomarker for Radiation Exposure and Microcirculatory Damage.Candidate protein biodosimeters of human exposure to ionizing radiation.Cytokines associated with toxicity in the treatment of recurrent glioblastoma with afliberceptRadiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in micePartial-Body Irradiation in Patients with Prostate Cancer Treated with IMRT Has Little Effect on the Composition of Serum Proteome.Serum Proteome Analysis for Profiling Predictive Protein Markers Associated with the Severity of Skin Lesions Induced by Ionizing RadiationAccurate accumulation of dose for improved understanding of radiation effects in normal tissue.Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes.Biomarker studies on radiotherapy to hepatocellular carcinoma.Selective expression of transthyretin in subtypes of lung cancer.Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity.Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer.Biomarkers in radiation oncology.Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays.Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray.Genomic Profile of Fatigued Men Receiving Localized Radiation Therapy.Candidate gene biodosimetry markers of exposure to external ionizing radiation in human blood: A systematic review.[Autoantibodies as the early diagnostic biomarkers for lung cancer].
P2860
Q27001184-C04DB0F6-C036-49A7-BDAE-40CEC85BBCF1Q27026683-AFF2FBBA-5B33-4EBF-977A-5AB0552538C1Q30361936-2DDF9E18-F453-4569-8AD8-8F485DB42704Q33252434-9069BAF0-8539-45A5-959E-3EA477DA938CQ33293388-544A3BED-12D3-425E-8EF1-B9826E0FB1B0Q33313121-D8050287-2413-4141-B87D-EEFA8B6427F0Q33319301-409C3978-596A-4F39-9A19-038D044CB9C1Q33580735-25EC4FE4-CC75-41B2-8FE8-BECA8BAE6E30Q33674367-4071E03E-82B8-41EC-945B-40EF9A92FE61Q33829971-47223A2E-29A5-4DA6-A982-DF3B39E83F2DQ33907123-E8EE95FB-E767-471D-8A32-2AE3FC0E937FQ33910359-25BCAA74-9185-423E-8B11-6EFF56211067Q34530393-1735AD38-7DED-46A4-BF4E-C48087D1E244Q34566189-5DBCFD9D-5558-4848-94C6-CD0B5D45C229Q34657835-3AD0906C-A734-4828-9C55-05BC139850C4Q34973585-01E869C5-A782-458F-9716-5C0D92AB3303Q35142492-ECD56BBF-5B25-4326-B500-1ED9E81F8878Q35210343-38D5F3EB-253D-4780-AACB-32565868E801Q35676132-0B8D625C-9940-4735-915E-40FEC70ED0F1Q36147848-50AC821F-FAC7-40DB-904E-24C9B76FBFAEQ36206616-E81CBA71-EDB9-4B8E-BC26-480F9AE1762DQ36627909-AEDBA834-3CB2-4317-88BC-0D6DDD6EC709Q36712746-086CCF59-2F50-4C03-AB1A-51EE1D906C3EQ36744400-13335134-9A75-4128-A74D-443E0090A086Q37566459-BBA5792F-087A-42C4-8529-870BD41EAD24Q37636452-89B78CE7-6E85-4782-83CD-779A71FE821FQ37695541-7C443325-D612-465A-BB32-73E9E8E5E402Q37708428-6AD41EE6-8030-48B6-B8A1-6B2BAEE4BFE9Q38081954-4722D0C0-62F2-4FD3-93B4-65995A62A54EQ38083433-C5A2FD3A-A079-4ACE-8191-69888EBEDFDAQ38788924-85381AAA-73A7-4B45-A446-2D661DD214A6Q39172554-6113AC53-E275-4857-95BE-D723561FBC83Q45119553-C3DC8986-C4D4-455B-8CD0-F08A0169833AQ47567437-6556D720-2CA0-4671-AC17-47CA993B8F3BQ47606195-60F3EFCD-B344-4924-8A23-51A9CAE21B3BQ48010555-C1B4C313-C5D4-48A3-B026-9DD1B3FE609BQ49986690-789853FB-A585-4D0A-A5A9-1F7A324D71D5Q52899597-8CFB2E34-17B9-4E7C-A54B-FDBD5DC27B65Q55312343-69632539-56A0-4864-A174-0771C13747C6Q55436520-7CB8E568-37CB-46D7-BCA4-08AB44186DFA
P2860
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Discovering clinical biomarker ...... with serum proteomic analysis.
@ast
Discovering clinical biomarker ...... with serum proteomic analysis.
@en
type
label
Discovering clinical biomarker ...... with serum proteomic analysis.
@ast
Discovering clinical biomarker ...... with serum proteomic analysis.
@en
prefLabel
Discovering clinical biomarker ...... with serum proteomic analysis.
@ast
Discovering clinical biomarker ...... with serum proteomic analysis.
@en
P2093
P1433
P1476
Discovering clinical biomarker ...... with serum proteomic analysis.
@en
P2093
C Norman Coleman
Cynthia Ménard
Donald Johann
Emanuel Petricoin
Gordon Whiteley
James Gulley
Kevin Camphausen
Lance Liotta
Mark Lowenthal
Mary Sproull
P304
P356
10.1158/0008-5472.CAN-05-3466
P407
P577
2006-02-01T00:00:00Z